Suppliers

Maximuscle beefs up GSK performance but OTC catches a cold

By 2012-02-07T13:02:00

MAXIMUSCLE-PROMAX

Lucozade maker GlaxoSmithKline has reported sales growth of 5% across its consumer healthcare business for 2011.

 

Already have an account? Sign in here

You’ve used up your article allowance

Sign up to read more stories for free

Register now